- The trend backdrop is active with a 26-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is constructive, supporting the smart-money activity read.
2230
SAU
Week ended 07 Aug 2026
Weekly Investor Report
Saudi Chemical Holding Company · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
8.07 SAR
-0.5%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 1.6% above the Trend Line and sits at 69.6% of its 52-week range. The latest completed week returned -0.5%, after a -2.7% four-week move. The latest news-sentiment score is 47/100.
Setup score
55
out of 100
Latest Close
8.07 SAR
7 Aug 2026
1W Return
-0.5%
latest completed week
4W Return
-2.7%
short-term follow-through
12W Return
-2.8%
quarterly tape
Trend Breadth
50.0%
26 of 52 weeks active
Volume Ratio
1.2x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- Latest weekly return ranks in the weaker part of its sector group.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.5%
Latest completed week; four-week move -2.7%.
Indicator stack
72/19
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
47/100
18 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 1.6% above the Trend Line and sits at 69.6% of its 52-week range. The latest completed week returned -0.5%, after a -2.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6512-week average 0.73
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.65Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -2.7% over four weeks, -2.8% over 12 weeks, and 12.7% over one year. The current trend has remained active for 26 consecutive weeks.
Performance by holding period
Active trend streak26 weeks
Active weeks in one year26
Trend breadth50.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.62Latest activity-pressure read.
Pressure change-247.8%Four-week change in activity pressure.
Leadership9.42Latest relative-leadership reading.
RS change-32.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment47/100
Weighted news tone is neutral across 18 relevant articles.
1 positive · 13 neutral · 4 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-10.1%Distance below the 52-week high.
13-week volatility2.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2613 weeks finished lower.
Best week+5.6%Week of 20 Mar.
Worst week-7.9%Week of 13 Mar.
Latest week-0.5%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains9
Flat weeks1
Modest losses10
Sharp losses3
Recent vol2.1%13-week weekly-return volatility.
Base vol4.0%52-week weekly-return volatility.
Up/down split24/27Count of positive and negative weeks in the 52-week window.
Average skew4.0% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSA Healthcare
4-week rank19 / 31
Group average0.0%
Trend breadth22.6%
Trend22.6%active weekly trend signals
MD29.0%positive activity pressure
RS19.4%positive relative leadership
Four-week leaders
IndustrySA Drug Manufacturers - Specialty & Generic
4-week rank2 / 4
Group average-1.2%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD50.0%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape57/100
Trend, activity pressure, participation, and risk combine to a 57/100 tape read.
Indicator analysis80/100Latest 12-week confirmation: trend 12/12, activity pressure 9/12, relative leadership 12/12.
Activity pressure 0.65; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment47/100Weighted news tone is neutral across 18 relevant articles.
Closing Bell: Saudi main market stable in Wednesday’s trading Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 8.07 SAR | -0.5% | 7.94 SAR | 7.63 SAR | -0.62 | 9.42 | 24.6M | On |
| 31 Jul 2026 | 8.11 SAR | -3.1% | 7.89 SAR | 7.61 SAR | -0.47 | 12.76 | 14.3M | On |
| 24 Jul 2026 | 8.37 SAR | -1.1% | 7.83 SAR | 7.59 SAR | -0.31 | 14.44 | 11.9M | On |
| 17 Jul 2026 | 8.46 SAR | 2.1% | 7.76 SAR | 7.56 SAR | 0.00 | 16.81 | 20.4M | On |
| 10 Jul 2026 | 8.29 SAR | 2.2% | 7.69 SAR | 7.53 SAR | 0.42 | 14.00 | 13.5M | On |
| 3 Jul 2026 | 8.11 SAR | -0.5% | 7.64 SAR | 7.50 SAR | 0.85 | 11.74 | 13.2M | On |
| 26 Jun 2026 | 8.15 SAR | -2.4% | 7.60 SAR | 7.48 SAR | 1.37 | 11.64 | 17.9M | On |
| 19 Jun 2026 | 8.35 SAR | -1.8% | 7.56 SAR | 7.45 SAR | 1.54 | 12.91 | 21.4M | On |
| 12 Jun 2026 | 8.50 SAR | -1.8% | 7.53 SAR | 7.42 SAR | 1.53 | 16.12 | 21.1M | On |
| 5 Jun 2026 | 8.66 SAR | 2.5% | 7.49 SAR | 7.38 SAR | 1.41 | 19.17 | 34.0M | On |
| 29 May 2026 | 8.45 SAR | 0.0% | 7.46 SAR | 7.35 SAR | 1.09 | 16.19 | 0 | On |
| 22 May 2026 | 8.45 SAR | 1.8% | 7.42 SAR | 7.31 SAR | 1.19 | 16.19 | 45.7M | On |
| 15 May 2026 | 8.30 SAR | 3.6% | 7.39 SAR | 7.28 SAR | 1.00 | 14.74 | 39.5M | On |
| 8 May 2026 | 8.01 SAR | -3.2% | 7.36 SAR | 7.24 SAR | 1.13 | 10.61 | 25.4M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.